OVPENS Platform
Pipeline
Developing Products That are
Potent, Enabling, Novel and Safe
Potent, Enabling, Novel and Safe
Open – collaborate with leading pharma, co-development with promising candidates
Vectors – include both viral (HSV) and non-viral (Exosome) vector development technologies as drug delivery mechanisms
-
Open VectorHarness the potential of viral and non-viral vector -
PotentDevelop novel vectors with outstanding potency -
EnablingAdvance efficacy of other therapy agents -
NovelPioneering the platform approach with novel modifications, applications and combinations -
SafeBio-derived vectors modified for optimized safety profile
